Jaguar Health, Inc. (JAGX) Net income 2016–2025
Jaguar Health, Inc. (JAGX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$53.6MFY2025 · since FY2016: -$14.7M → -$53.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$53.6M | -39.2% |
| FY2024 | -$38.5M | -91766.3% |
| FY2023 | -$41,900 | +13.4% |
| FY2022 | -$48,400 | +8.0% |
| FY2021 | -$52,600 | +99.8% |
| FY2020 | -$33.8M | +12.3% |
| FY2019 | -$38.5M | -19.9% |
| FY2018 | -$32.1M | -46.3% |
| FY2017 | -$22.0M | -49.1% |
| FY2016 | -$14.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More JAGX financial trends
JAGX RevenueJAGX Net marginJAGX Gross profitJAGX Gross marginJAGX Operating incomeJAGX Operating marginJAGX Operating cash flowJAGX Free cash flowJAGX Capital expendituresJAGX Return on equityJAGX Stock buybacksJAGX Dividends paidJAGX Total assetsJAGX Total liabilitiesJAGX Shareholders’ equityJAGX overview →